# Zoledronate In the Prevention of Paget's Disease: Long Term Extension

> **NCT03859895** · — · ENROLLING_BY_INVITATION · sponsor: **University of Edinburgh** · enrollment: 287 (estimated)

## Conditions studied

- Paget Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03859895
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-04-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-05
- **Target enrollment:** 287 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859895, "Zoledronate In the Prevention of Paget's Disease: Long Term Extension". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03859895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*